Mersana Therapeutics Inc (NAS:MRSN)
$ 2.48 -0.07 (-2.75%) Market Cap: 306.36 Mil Enterprise Value: 191.34 Mil PE Ratio: 0 PB Ratio: 248.00 GF Score: 41/100

Q4 2023 Mersana Therapeutics Inc Earnings Call Transcript

Feb 28, 2024 / 01:00PM GMT
Release Date Price: $4.85 (+13.58%)
Operator

Good morning, and welcome to the Mersana Therapeutics fourth-quarter 2023 conference call and webcast. (Operator Instructions) Please note this call is being recorded.

I would now like to turn the call over to Jason Fredette, Senior Vice President, Investor Relations and Corporate Communications.

Jason Fredette
Mersana Therapeutics Inc - SVP, IR and Corporate Communications

Thank you, operator, and good morning, everyone.

Before we begin, please note that this call will contain forward-looking statements within the meaning of federal securities laws. These statements may include, but are not limited to, those relating to our platforms, product candidates, business strategy, clinical trial execution and results, business development efforts, and cash runway. Each of these forward-looking statements is subject to risks and uncertainties that could cause actual results to differ materially from those projected in such statements.

These risks and uncertainties are discussed in our quarterly report on Form 10-Q filed with the Securities

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot